Effects of Controlled-Release Metoprolol on Total Mortality, Hospitalizations, and Well-being in Patients With Heart Failure
Åke Hjalmarson(Sahlgrenska University Hospital), for the MERIT-HF Study Group, John Kjekshus(Nuffield Health), Guðmundur Þorgeirsson(Sahlgrenska University Hospital), Sidney Goldstein(Sahlgrenska University Hospital), Finn Waagstein(Apple (Israel)), Björn Fagerberg(Sahlgrenska University Hospital), John Wikstrand(Nuffield Health), Lars Gullestad(Sahlgrenska University Hospital), Dia El Allaf(Sahlgrenska University Hospital), Stephen Ball(Sahlgrenska University Hospital), Jan Aldershvile(Sahlgrenska University Hospital), Stephen S. Gottlieb(University of Maryland, Baltimore), Prakash Deedwania(San Francisco VA Medical Center), Johan Herlitz(Sahlgrenska University Hospital), J Kuch(Sahlgrenska University Hospital), Jiří Vítovec(Sahlgrenska University Hospital), Peter H.J.M. Dunselman(Sahlgrenska University Hospital), Rainer Dietz(Heidelberg University), András Jánosi(Apple (Israel)), Matti Halinen(Sahlgrenska University Hospital), Hans Wedel(Sahlgrenska University Hospital), Karl-Ludwig Neuhaus(Sahlgrenska University Hospital), Peter Rickenbacher(Sahlgrenska University Hospital)
Cited by 1,393
Related Papers
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial
|The Lancet|1998|5.8k
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
|The Lancet|2002|5.4k
Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects
|New England Journal of Medicine|2007|4.6k
Lifestyle, Diabetes, and Cardiovascular Risk Factors 10 Years after Bariatric Surgery
|New England Journal of Medicine|2004|4.5k